Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-15

Clinical Trial Update: A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding trial of Lu-AG09222 in adults with migraine who have not responded to prior preventive treatments is ongoing but currently not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lu AG09222

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Migraine | Phase 2 | Status: ACTIVE_NOT_RECRUITING